WBAL: Anti-viral treatment available in Maryland to treat monkeypox
August 23, 2022 | Lisa Robinson
What do you do if you think you have monkeypox?
All 50 U.S. states have reported at least one monkeypox case. Of the more than 15,000 cases nationwide, Maryland accounts for 379 monkeypox infections.
Smallpox therapies may be used, although data on their effectiveness for the virus is limited. Vaccines are hard to come by, but there is an anti-viral treatment available.
At the University of Maryland School of Medicine's Institute for Human Virology THRIVE program, patients who think they have monkeypox can be evaluated and treated if they meet criteria set by the Centers for Disease Control and Prevention. People with severe disease or who are at risk for severe disease will be considered.
Contact
Vanessa McMains
Director of Media & Public Affairs
Institute of Human Virology
University of Maryland School of Medicine
vmcmains@ihv.umaryland.edu
443-875-6099
Related stories
Wednesday, January 18, 2023
Baltimore Banner: Hunt for infectious disease treatments takes on new urgency
When monkeypox cases began spiking in early June, some of those infected and at risk were dismayed that there weren’t proven therapies ready. There was a promising treatment, tested in animals but not humans, for the infections regularly seen in Africa but rarely reported in Europe or North America. The drug was used sparingly before the emergency began abating. But instead of putting the tecovirimat, or TPOXX, back on the shelf, researchers at Johns Hopkins and elsewhere launched a major study to confirm it worked for monekypox, now known as mpox.
Tuesday, May 31, 2022
Medscape: Fatigue Affects Cognitive Processing Speed in the Aging HIV Population
Successful aging is something that most of us strive for. But with aging comes a pervasive condition called fatigue that, in many older adults, interferes with everyday functioning, mental health, social support, and overall quality of life. The relationship between fatigue and cognitive and functional impairment is one of particular interest in people living with HIV (PWH), a patient population that is disproportionately affected but whose lifespan now matches that of the general population.
Tuesday, May 24, 2022
Baltimore Sun: Monkeypox ‘isn’t COVID,’ but CDC still wants public to be aware of cases
Officials from the U.S. Centers for Disease Control and Prevention warned the public and medical providers Monday to be on alert for possible cases of monkeypox as it counts up to five cases of the normally rare disease around the nation. But the officials say the threat to the general public remains low, as it’s just not as easily spread as other diseases such as COVID-19. Rather, it takes touching or sharing fluids with someone with the characteristic monkeypox rash.
Friday, May 20, 2022
Quartz: The most advanced treatments for monkeypox were developed to address the wrong threat
A few cases of monkeypox have been registered in Europe and North America, far from West and Central Africa where outbreaks typically emerge. With covid still very much ongoing and fresh memories of early 2020, the alert has gone up quickly, lifting the shares of makers of the medications that would be needed to treat a monkeypox outbreak.
Friday, February 04, 2022
WYPR: How the COVID pandemic rattled HIV testing
The COVID pandemic did not end the HIV-AIDS epidemic; it may have obscured it for a while, raising hurdles to getting tested for HIV.